奥美拉唑治疗上消化道出血疾病的观察及安全性探析

Observation and Safety Analysis of Omeprazole in the Treatment of Upper Gastrointestinal Hemorrhage

目的探讨奥美拉唑治疗上消化道出血疾病的观察及安全性。方法选择我院消化道出血疾病患者,总数100例,收集时间2017年1月至2019年1月。随机分组,法莫替丁治疗组对本次就诊上消化道出血疾病患者采取法莫替丁治疗,奥美拉唑治疗组对本次就诊消化道出血疾病患者则实施奥美拉唑治疗。比较效果。结果奥美拉唑治疗组上消化道出血疾病疗效、上消化道出血疾病出血停止时间、住院时间、胃泌素等消化功能指标以及血红蛋白监测值相比较法莫替丁治疗组更好,P <0.05。奥美拉唑治疗组和法莫替丁治疗组安全性相似,P> 0.05。结论奥美拉唑治疗上消化道出血疾病效果确切,可获得理想效果。

Objective To investigate the safety of omeprazole in the treatment of upper gastrointestinal hemorrhage. Methods 100 patients with digestive tract hemorrhage in our hospital were collected from January 2017 to January 2019. Randomized group, famotidine treatment group for the treatment of upper gastrointestinal hemorrhage patients with famotidine treatment, omeprazole treatment group for the treatment of gastrointestinal hemorrhage patients with omeprazole treatment. Compare the results. Result Omeprazole treatment group had better curative effect on upper gastrointestinal hemorrhage disease, stop time of upper gastrointestinal hemorrhage disease, hospitalization time, gastrin and hemoglobin monitoring value than famotidine treatment group(P<0.05). The safety of omeprazole group and famotidine group was similar(P>0.05). Conclusion Omeprazole is effective in the treatment of upper gastrointestinal hemorrhage and can achieve ideal results.